Acumen Research and Consulting has announced the addition of the “Pharmacovigilance Outsourcing Market” report to their offering.
The Pharmacovigilance Outsourcing Market Industry Report 2019 is an in depth study analyzing the current state of the Pharmacovigilance Outsourcing Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Pharmacovigilance Outsourcing Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Pharmacovigilance Outsourcing Market also discusses the opportunity areas for investors.
Download Sample Copy of this Report@ https://www.acumenresearchandconsulting.com/request-sample/1094
Market Players:
Some of the key players include Bioclinica, Clintec, Covance, Medpace Holdings, Oracle Corporation, iGATE Corporation, Accenture, iMED Global Corporation, Symogen, Ergomed, IBM Corporation, IQVIA, MarksMan Healthcare, Parexel, SIRO Clinpharm and Novartis
The Major Market Segments of Global Pharmacovigilance Outsourcing Market are as below:
Market Segmentation
Pharmacovigilance Outsourcing Market, By Service
- Pre-marketing services
- Clinical pharmacovigilance services
- Case processing services
- Safety data management services
- Medical review
- Post-marketing services
- Knowledge process outsourcing services
- IT solutions and services
- Others
Pharmacovigilance Outsourcing Market, By Service Provider
- Contract research organizations (CROs)
- Business process outsourcing (BPOs)
Global Pharmacovigilance outsourcing Market, by Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
View Detail Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1094
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Pharmacovigilance Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmacovigilance Outsourcing Market By Service
1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
1.2.2.3. Pre-marketing services
1.2.2.4. Post-marketing services
1.2.2.5. Others
1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
1.2.3.3. Contract research organizations (CROs)
1.2.3.4. Business process outsourcing (BPOs)
1.2.3.5. Others
1.2.4. Pharmacovigilance Outsourcing Market by Geography
1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.1.1. Definition of Pharmacovigilance Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmacovigilance Outsourcing Market By Service
1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
1.2.2.3. Pre-marketing services
1.2.2.4. Post-marketing services
1.2.2.5. Others
1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
1.2.3.3. Contract research organizations (CROs)
1.2.3.4. Business process outsourcing (BPOs)
1.2.3.5. Others
1.2.4. Pharmacovigilance Outsourcing Market by Geography
1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
CHAPTER 4. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE
4.1. Global Pharmacovigilance Outsourcing Revenue By Service
4.2. Pre-marketing services
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Post-marketing services
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.2. Pre-marketing services
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Post-marketing services
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE PROVIDER
5.1. Global Pharmacovigilance Outsourcing Revenue By Service Provider
5.2. Contract research organizations (CROs)
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Business process outsourcing (BPOs)
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.2. Contract research organizations (CROs)
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Business process outsourcing (BPOs)
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. NORTH AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
6.1. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 7. EUROPE PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
7.1. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 9. LATIN AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
9.1. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 10. MIDDLE EAST PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
10.1. Middle East Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 11. AFRICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
11.1. Africa Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Provider, 2015 – 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Bioclinica
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Clintec
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Covance
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medpace Holdings
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Oracle Corporation
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. iGATE Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Accenture
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. iMED Global Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Symogen
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ergomed
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. IBM Corporation
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. IQVIA
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. MarksMan Healthcare
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Parexel
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. SIRO Clinpharm
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Novartis
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies
12.17. Others
12.17.1. Company Snapshot
12.17.2. Overview
12.17.3. Financial Overview
12.17.4. Product Portfolio
12.17.5. Key Developments
12.17.6. Strategies
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Clintec
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Covance
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medpace Holdings
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Oracle Corporation
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. iGATE Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Accenture
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. iMED Global Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Symogen
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ergomed
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. IBM Corporation
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. IQVIA
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. MarksMan Healthcare
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Parexel
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. SIRO Clinpharm
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Novartis
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies
12.17. Others
12.17.1. Company Snapshot
12.17.2. Overview
12.17.3. Financial Overview
12.17.4. Product Portfolio
12.17.5. Key Developments
12.17.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/pharmacovigilance-outsourcing-market
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
0 Comments
Get More Detail Study, Visit Here: https://www.acumenresearchandconsulting.com/